Shuttle Pharmactcls Hldgs Inc.
13F holders, Q3 2025 (September 30)6holders +1
2new positions
1sold out
$3.55avg. 13F price*
At the end of Q3 2025, 6 institutions reported holding Shuttle Pharmactcls Hldgs Inc. in their 13F filings, up 1 from Q2 2025. 2 opened new positions and 1 sold out. The largest holders were DRW Securities, LLC ($152K), Tower Research Capital LLC (TRC) ($4K) and Morgan Stanley ($96).
- Company
- Shuttle Pharmactcls Hldgs Inc.
- CUSIP
- 825693401
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $152K |
| Exits | 1 | $4K |
All 13F filers, Q2 2025 → Q3 2025: 43,754 shares bought and 4,359 shares sold, net +39,395 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| DRW Securities, LLC | 0.01% | New | 42,830 | $152K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +725.2% | 1,015 | $4K |
| Morgan Stanley | 0.00% | New | 27 | $96 |
| Bank of America Corp. | 0.00% | Add +166.7% | 8 | $28 |
| UBS Group AG | 0.00% | Reduce -99.8% | 8 | $28 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 2 | $7 |
"% of holder's portfolio" is SHUTTLE PHARMACTCLS HLDGS IN's weight in each manager's 13F, not the share of Shuttle Pharmactcls Hldgs Inc. the manager owns.